Pharmaceuticals
Board Meeting31 March 2026 at 04:39 am

Divis Laboratories Ltd Announces Closure of Trading Window from April 01, 2026

AI Summary

Divis Laboratories Ltd has announced the closure of the trading window from April 01, 2026 till 48 hours after the declaration of audited financial results for the quarter and financial year ended March 31, 2026. This decision is in accordance with the Company’s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons, Immediate Relatives of Designated Persons and Insiders. The date of the Board meeting for the declaration of the audited financial results will be intimated in due course.

Key Highlights

  • Divis Laboratories Ltd announces closure of trading window from April 01, 2026
  • Trading window to remain closed till 48 hours after declaration of audited financial results for the quarter and financial year ended March 31, 2026
  • Announcement in accordance with the Company’s Code of Conduct
  • Board meeting date for declaration of audited financial results to be intimated later
  • Decision affects trading by Designated Persons, Immediate Relatives of Designated Persons and Insiders